A deep and consistent study will be developed with an increase in the human sampling for
better understanding the intervention efficacy of this intelligence medicine integrator, the
Mora® Nova method. These in silico experiments when associated with the bioresonance
frequencies from stimulated hemolymph compounds of the freshwater bivalve A. cygnea, may lead
us to expect high plasticity and immunological potential.
Obviously, additional in vitro studies in future, with adequate culture cell lineages in
different conditions and with bioresonance treatment by Mora® Nova method, should also be
accomplished with hemolymph/plasma interference to confirm the pertinence, and the real
efficacy on SARS / COVID-19 infection as well as to clarify the respective biological
mechanisms.
In addition, to analyze and evaluate any specific bioactive compound from the induced
hemolymph condition needs molecular experiments which can give deep structural information
concerning any efficient molecule against the SARS / COVID-19 virus lineage and respective
mutants. Effectively, according to current scientific opinion, the virus mutation phenomenon
leads to great and problematic difficulty for maintaining the collective and human global
immunization. In this case, the present Mora methodology offers a very functional, dynamic,
and efficient process when combined with a biological model, as the bivalve A. cygnea, with
high plasticity and eventual molecular reconstructive adaptation. This Mora procedure can
extend to other immune-depressive diseases namely cancer, rheumatoid arthritis, and
neurodegenerative diseases combining with respective stimulated bivalve fluids. It suggests
opening a promising future perspective when applied to large human sampling as well as with
in vitro cellular assays.
In addition, to explore this research with in vitro cell cultures and to do the
characterization and the effects from bio-compounds on similar diseases is our close
objective.